|
Research Management and Support
|
RMS ES 2016
|
$320,501,735
|
$20,000
|
N/A
|
National Institutes of Health
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-47S1
|
$142,498
|
$2,850
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-47
|
$2,645,581
|
$52,912
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,014,935
|
$20,299
|
Barr, Frederic
|
CCR (NCI)
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,305,516
|
$215,276
|
Bilusic, Marijo
|
CCR (NCI)
|
|
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs
|
ZIA BC 007363
|
$287,033
|
$143,516
|
Burke, Terrence
|
CCR (NCI)
|
|
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
|
ZIA BC 010791
|
$1,047,897
|
$209,579
|
Carrington, Mary
|
CCR (NCI)
|
|
Biologic Determinants of the Natural History of AIDS-Defining Cancers in Uganda
|
5U54CA190146-03
|
$693,281
|
$339,708
|
CASPER, COREY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Modeling KSHV latency in vivo
|
4R01CA103646-10
|
$328,499
|
$328,499
|
CESARMAN, ETHEL
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Early events of in vitro KSHV infection
|
4R01CA168472-05
|
$320,588
|
$320,588
|
CHANDRAN, BALA
|
ROSALIND FRANKLIN UNIV OF MEDICINE & SCI
|
|
KSHV interactions with host inflammasome components
|
5R01CA180758-03
|
$320,588
|
$320,588
|
CHANDRAN, BALA
|
ROSALIND FRANKLIN UNIV OF MEDICINE & SCI
|
|
CD206 Targeted Therapy for Kaposi Sarcoma and Tumor Associated Macrophages
|
1R44CA206788-01
|
$232,464
|
$232,464
|
COPE, FREDERICK
|
NAVIDEA BIOPHARMACEUTICALS, INC.
|
|
Receptor Mediated SPECT Imaging Of Kaposi Sarcoma With 99mTc-Tilmanocept
|
4R44CA192859-02
|
$633,492
|
$633,492
|
COPE, FREDERICK
|
NAVIDEA BIOPHARMACEUTICALS, INC.
|
|
Immune Modulation by Gammaherpesviruses
|
4R01CA168477-05
|
$234,200
|
$234,200
|
COSCOY, LAURENT
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
Viral Oncology Training Grant
|
5T32CA009111-38
|
$378,220
|
$37,822
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Herpesviral Oncogenesis, Latency and Reactivation
|
2P01CA019014-37
|
$1,811,800
|
$1,014,608
|
DAMANIA, BLOSSOM
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Role of KSHV viral proteins in signaling and pathogenesis
|
4R01CA096500-14
|
$281,108
|
$281,108
|
DAMANIA, BLOSSOM
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Abramson Cancer Center Support Grant
|
2P30CA016520-40
|
$7,975,543
|
$159,511
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-40S1
|
$31,250
|
$625
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-40S2
|
$499,967
|
$9,999
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-40S3
|
$200,000
|
$4,000
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Cancer Center Support Grant
|
3P30CA047904-28S1
|
$115,192
|
$2,304
|
DAVIDSON, NANCY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
3P30CA047904-28S2
|
$60,000
|
$1,200
|
DAVIDSON, NANCY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
3P30CA047904-28S3
|
$199,837
|
$3,997
|
DAVIDSON, NANCY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
3P30CA047904-28S4
|
$749,690
|
$14,994
|
DAVIDSON, NANCY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
5P30CA047904-28
|
$5,129,654
|
$102,593
|
DAVIDSON, NANCY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma
|
2R01CA163217-06
|
$342,759
|
$171,380
|
DITTMER, DIRK
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support Grant
|
5P30CA016042-41
|
$4,295,192
|
$343,615
|
DORSHKIND, KENNETH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-18S3
|
$1,479,340
|
$118,347
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-18S4
|
$124,995
|
$10,000
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-18S5
|
$749,999
|
$60,000
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-18S6
|
$60,000
|
$4,800
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
HIV AIDS cancer match, U.S.
|
ZIA CP010150-10071
|
$196,073
|
$58,822
|
Engels, Eric
|
DCEG (NCI)
|
|
Cancer risk in solid organ transplant recipients and endstage renal disease
|
ZIA CP010150-10362
|
$240,777
|
$24,078
|
Engels, Eric
|
DCEG (NCI)
|
|
Early Stage Diagnosis of Kaposi's Sarcoma in Limited Resource Settings using KS-Detect
|
1UH2CA202723-01
|
$500,000
|
$500,000
|
ERICKSON, DAVID
|
CORNELL UNIVERSITY
|
|
The 19th International Workshop on KSHV and Related Agents
|
1R13CA210906-01
|
$5,000
|
$5,000
|
FENG, PINGHUI
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Regulation of KSHV infection and replication by MAPK pathways
|
4R01CA124332-10
|
$304,095
|
$304,095
|
GAO, SHOU-JIANG
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Mechanism of KSHV-induced angiogenesis
|
5R01CA132637-08
|
$391,875
|
$391,875
|
GAO, SHOU-JIANG
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Targeting KSHV malignancies and persistent infection
|
5R01CA197153-02
|
$377,438
|
$377,438
|
GAO, SHOU-JIANG
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Disruption of Cellular RNA Processing by Kaposi's Sarcoma-Associated Herpesvirus
|
5R01CA136367-07
|
$342,543
|
$171,272
|
GLAUNSINGER, BRITT
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
Addressing Herpesvirus-associated Cancers through the UNC-Malawi Cancer Consortiu
|
5U54CA190152-03
|
$699,897
|
$377,944
|
GOPAL, SATISH
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$373,564
|
$37,356
|
Gottesman, Michael
|
CCR (NCI)
|
|
Studies on drug resistance in HIV-related Kaposi's sarcoma
|
ZIA BC 011730
|
$149,425
|
$37,356
|
Gottesman, Michael
|
CCR (NCI)
|
|
Kaposi's Sarcoma-associated Herpesvirus Mimics of Cellular microRNAs
|
5R01CA180813-03
|
$320,588
|
$320,588
|
GOTTWEIN, EVA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
2P30CA014089-41
|
$6,354,897
|
$762,588
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-41S1
|
$59,999
|
$7,200
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-41S2
|
$37,500
|
$4,500
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Medical Oncology HIV-AIDS Clinical Research
|
ZID BC 011683
|
$173,361
|
$52,008
|
Gulley, James
|
CCR (NCI)
|
|
Molecular Basis of KSHV oncogenesis
|
1R35CA200422-01
|
$652,549
|
$652,549
|
JUNG, JAE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
KSHV Persistence and Pathogenesis
|
4P01CA180779-04
|
$1,472,214
|
$736,107
|
JUNG, JAE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
Total relevant funding to Kaposi Sarcoma for this search: $28,270,267
|